Literature DB >> 11014351

Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis.

R J François1, D L Gardner, E J Degrave, E G Bywaters.   

Abstract

OBJECTIVE: To systematically study the histopathology of sacroiliitis in ankylosing spondylitis (AS) at 5 different stages of the disease.
METHODS: Two independent observers assessed 75 microscopic features in the sacroiliac (SI) joints in 12 cases of AS (5 biopsies, 7 autopsies) and in 22 control cases (all autopsies).
RESULTS: In AS, synovitis, pannus formation, myxoid marrow, superficial cartilage destruction, enthesitis, intraarticular fibrous strands, new bone formation, and bony ankylosis were significantly more frequent than in control cases, in which there was more endochondral bone within deep-zone articular cartilage. Cartilaginous fusion occurred in both groups, but much earlier in AS. There was no residual synovium when the joint lumen was totally occluded. Mild but destructive synovitis and myxoid subchondral bone marrow were the earliest changes identified in AS. These lesions destroyed the adjacent articular tissues, a loss that was followed to varying degrees by fibrous scarring, woven bone, and new cartilage. The original cartilages also fused, and chondral fusion was the predominant mode of ankylosis. Both the original and the reparative cartilaginous tissues were replaced by bone. Active enthesitis occurred in 2 advanced and 3 late cases; fibrous scar tissue, presumed to represent previous enthesitis, was observed in all stages except the earliest. Paraarticular bone was at first dense, and later porotic.
CONCLUSION: In the sacroiliitis of AS, two findings predominate: 1) synovitis and subchondral bone marrow changes offer a more rational explanation for widespread joint destruction than does enthesitis; and 2) an unusual form of chondroid metaplasia contributes to ankylosis.

Entities:  

Mesh:

Year:  2000        PMID: 11014351     DOI: 10.1002/1529-0131(200009)43:9<2011::AID-ANR12>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  51 in total

Review 1.  New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy.

Authors:  J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  Advances in the understanding of entheseal inflammation.

Authors:  Dennis McGonagle; Michael Benjamin; Helena Marzo-Ortega; Paul Emery
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

Review 3.  Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.

Authors:  Amy S Kehl; Maripat Corr; Michael H Weisman
Journal:  Arthritis Rheumatol       Date:  2016-02       Impact factor: 10.995

Review 4.  [Ankylosing spondylitis--current state of imaging including scoring methods].

Authors:  C E Althoff; K G Hermann; J Braun; J Sieper
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

Review 5.  Mechanisms of pathologic new bone formation.

Authors:  Kurt de Vlam; Rik J U Lories; Frank P Luyten
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 6.  The balance of tissue repair and remodeling in chronic arthritis.

Authors:  Rik Lories
Journal:  Nat Rev Rheumatol       Date:  2011-10-18       Impact factor: 20.543

7.  The value of sacroiliac pain provocation tests in early active sacroiliitis.

Authors:  Salih Ozgocmen; Zulkif Bozgeyik; Mehtap Kalcik; Arafe Yildirim
Journal:  Clin Rheumatol       Date:  2008-05-06       Impact factor: 2.980

Review 8.  Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics.

Authors:  Heiner Appel; Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

9.  Serum hyaluronic acid levels in patients with ankylosing spondylitis.

Authors:  Mehmet Tuncay Duruöz; Yasemin Turan; Lale Cerrahoglu; Banu Isbilen
Journal:  Clin Rheumatol       Date:  2007-10-23       Impact factor: 2.980

Review 10.  Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease?

Authors:  Lode Melis; Dirk Elewaut
Journal:  Arthritis Res Ther       Date:  2009-06-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.